The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial

BACKGROUND AND OBJECTIVES: The calcimimetic cinacalcet reduced the risk of death or cardiovascular (CV) events in older, but not younger, patients with moderate to severe secondary hyperparathyroidism (HPT) who were receiving hemodialysis. To determine whether the lower risk in younger patients migh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin J Am Soc Nephrol
Egile Nagusiak: Parfrey, Patrick S., Drüeke, Tilman B., Block, Geoffrey A., Correa-Rotter, Ricardo, Floege, Jürgen, Herzog, Charles A., London, Gerard M., Mahaffey, Kenneth W., Moe, Sharon M., Wheeler, David C., Kubo, Yumi, Dehmel, Bastian, Goodman, William G., Chertow, Glenn M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2015
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4422239/
https://ncbi.nlm.nih.gov/pubmed/25710802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07730814
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak